(5-tert-Butyl-4-methoxy-2-methyl-phenyl)-(1H-imidazol-2-yl)-amine

ID: ALA78190

Chembl Id: CHEMBL78190

PubChem CID: 10682720

Max Phase: Preclinical

Molecular Formula: C15H21N3O

Molecular Weight: 259.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C)c(Nc2ncc[nH]2)cc1C(C)(C)C

Standard InChI:  InChI=1S/C15H21N3O/c1-10-8-13(19-5)11(15(2,3)4)9-12(10)18-14-16-6-7-17-14/h6-9H,1-5H3,(H2,16,17,18)

Standard InChI Key:  QELYRGGNEIAOKD-UHFFFAOYSA-N

Associated Targets(Human)

ADRA1A Tclin Adrenergic receptor alpha-1 (948 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adra2b Alpha-2b adrenergic receptor (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 259.35Molecular Weight (Monoisotopic): 259.1685AlogP: 3.77#Rotatable Bonds: 3
Polar Surface Area: 49.94Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.18CX Basic pKa: 8.62CX LogP: 3.88CX LogD: 3.01
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.88Np Likeness Score: -0.81

References

1. Munk SA, Harcourt DA, Arasasingham PN, Burke JA, Kharlamb AB, Manlapaz CA, Padillo EU, Roberts D, Runde E, Williams L, Wheeler LA, Garst ME..  (1997)  Synthesis and evaluation of 2-(arylamino)imidazoles as alpha 2-adrenergic agonists.,  40  (1): [PMID:9016324] [10.1021/jm9605142]

Source